Issued Patents All Time
Showing 1–25 of 65 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12421294 | Truncated epiderimal growth factor receptor (EGFRt) for transduced t cell selection | — | 2025-09-23 |
| 12312416 | Fluorescein-specific cars exhibiting optimal t cell function against FL-PLE labelled tumors | James Matthaei | 2025-05-27 |
| 12269862 | Methods of use for CAR T cells | Philip S. Low, Haiyan Chu, Yingjuan June Lu, Christopher Paul Leamon, Leroy W. WHEELER, II +1 more | 2025-04-08 |
| 12258397 | Production of engineered T-cells by sleeping beauty transposon coupled with methotrexate selection | Suzie Hwang Pun, Nataly Kacherovsky | 2025-03-25 |
| 12240870 | Sequencing method for CAR T cell therapy | Richard MESSMANN, Christopher Paul Leamon, Haiyan Chu, Yingjuan June Lu, Philip S. Low +3 more | 2025-03-04 |
| 12233090 | Bispecific or-gate chimeric antigen receptor responsive to CD20 and CD19 | Yvonne Y. Chen, Eugenia Zah | 2025-02-25 |
| 12226435 | Bispecific OR-gate chimeric antigen receptor responsive to CD20 and CD19 | Yvonne Y. Chen, Eugenia Zah | 2025-02-18 |
| 12202897 | Drug regulated transgene expression | — | 2025-01-21 |
| 12180457 | Closed-system manufacturing process for CAR-T cells | Joshua Gustafson | 2024-12-31 |
| 12173071 | Methods and compositions comprising B7H3 chimeric antigen receptors | Adam Johnson | 2024-12-24 |
| 12152079 | Nucleic acids encoding IL-13 receptor alpha 2 (IL13Ra2) chimeric antigen receptor for tumor specific T cell immunotherapy | Giacomo Tampella | 2024-11-26 |
| 12098208 | Early intervention methods to prevent or ameliorate toxicity | Rebecca Gardner | 2024-09-24 |
| 12091459 | Bispecific chimeric antigen receptors, encoding polynucleotides and use of receptors thereof to treat cancer | — | 2024-09-17 |
| 12053491 | Bispecific OR-gate chimeric antigen receptor responsive to CD19 and CD20 | Yvonne Y. Chen, Eugenia Zah | 2024-08-06 |
| 11884930 | Method of inactivating a glucocorticoid receptor gene in an isolated cell | Andreas Reik, Michael C. Holmes, Philip D. Gregory, Dale Ando | 2024-01-30 |
| 11851649 | Generating mammalian T cell activation inducible synthetic promoters (SYN+PRO) to improve T cell therapy | Jia Wei | 2023-12-26 |
| 11826384 | Genetic engineering of macrophages for immunotherapy | Courtney Crane, Kara White Moyes, Nicole Lieberman | 2023-11-28 |
| 11779602 | Methods of use for CAR T cells | Philip S. Low, Haiyan Chu, Yingjuan June Lu, Christopher Paul Leamon, Leroy W. WHEELER, II +1 more | 2023-10-10 |
| 11760804 | Early intervention methods to prevent or ameliorate toxicity | Rebecca Gardner | 2023-09-19 |
| 11649288 | Phospholipid ether (PLE) CAR T cell tumor targeting (CTCT) agents | James Matthaei | 2023-05-16 |
| 11639387 | Bispecific chimeric antigen receptors, encoding polynucleotides thereof and methods of use thereof to treat disease | — | 2023-05-02 |
| 11518814 | Early intervention methods to prevent or ameliorate toxicity | Rebecca Gardner | 2022-12-06 |
| 11458167 | Bispecific CAR T-cells for solid tumor targeting | — | 2022-10-04 |
| 11414486 | Transgene genetic tags and methods of use | Adam Johnson | 2022-08-16 |
| 11408005 | Chimeric transcription factor variants with augmented sensitivity to drug ligand induction of transgene expression in mammalian cells | Tracy Ooi, Jia Wei | 2022-08-09 |